 |
 |

Roux-en-Y After Gastric Bypass—Reply
John W. Harmon, MD
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
In reply
I thank Dr Csendes for his interest in our article about the relationship between bile reflux and adenocarcinoma of the esophagus. As he points out, we focused exclusively on animal data in this article. The data were generated not only in our own laboratory but also in several other laboratories, and all the results confirm the role of bile reflux in producing adenocarcinoma in the animal model.
I personally have followed Dr Csendes' work with the Roux-en-Y gastrojejunostomy with great interest. I hope his findings are confirmed in a prospective multicenter study. In that case, the Roux-en-Y will become the standard of care for patients with Barrett syndrome, and the clinical importance of bile reflux into the esophagus will be incontrovertible. I appreciate his bringing this highly relevant work to the attention of the readers of the Archives.
AUTHOR INFORMATION
Correspondence: Dr Harmon, Department of . . . [Full Text of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Gastric Bypass: Why Roux-en-Y? A Review of Experimental Data
Brendan J. Collins, Tomoharu Miyashita, Michael Schweitzer, Thomas Magnuson, and John W. Harmon
Arch Surg. 2007;142(10):1000-1003.
ABSTRACT
| FULL TEXT
RELATED LETTER
Roux-en-Y After Gastric Bypass
Attila Csendes
Arch Surg. 2008;143(8):808.
EXTRACT
| FULL TEXT
|